查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1760837

全球血管闭合装置市场

Vascular Closure Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 477 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球血管闭合装置市场规模将达到 14 亿美元

全球血管闭合装置市场规模预计在2024年为9.382亿美元，预计到2030年将达到14亿美元，2024年至2030年的复合年增长率为7.5%。被动式闭合器是本报告分析的细分市场之一，预计其复合年增长率为8.2%，到分析期结束时市场规模将达到9.963亿美元。主动闭合器细分市场在分析期间的复合年增长率预计为6.7%。

美国市场规模估计为 3.871 亿美元，中国市场预计复合年增长率为 8.8%

美国血管闭合装置市场规模预计2024年达到3.871亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到1.54亿美元，在2024-2030年的分析期间内，复合年增长率为8.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率分别为6.5%和6.8%。在欧洲，预计德国的复合年增长率约为7.1%。

全球血管闭合装置市场－主要趋势与驱动因素摘要

什么是血管闭合装置？

血管闭合装置 (VCD) 是用于在心血管手术（例如血管造影术和血管成形术）后封闭动脉穿刺部位的医疗器械。与传统的手动压迫方法相比，这些装置取得了重大进展，提高了患者的舒适度并缩短了止血所需的时间。 VCD 分为几类，包括胶原蛋白栓塞、缝合系统和夹式系统，每种系统都旨在快速可靠地封闭动脉穿刺部位。使用 VCD 可最大限度地降低出血和血管损伤等併发症的风险，促进患者更快康復并缩短住院时间。

科技变革如何影响 VCD 市场？

技术进步引领血管闭合装置设计和功能创新的前沿。近期趋势包括生物可吸收材料，这些材料可在体内自然溶解，从而降低异物残留在体内导致感染和其他长期併发症的风险。此外，装置部署机制的进步带来了使用者友善的设计和更稳定的闭合效果。影像技术也得到了改进，使医生能够精确放置血管闭合器 (VCD)，从而使手术更加有效和安全。

血管闭合装置有哪些临床及经济效益？

从临床角度来看，VCD 可显着改善患者预后，降低与血管网路基地台相关的併发症发生率。 VCD 允许患者在术后立即下床活动，这对于老年患者和行动不便的患者至关重要。从经济角度来看，使用 VCD 可缩短术后照护时间，并最大限度地减少恢復期对额外医护人员的需求，从而降低医疗机构的成本。 VCD 在优化医院患者吞吐量方面也发挥重要作用，使更多患者能够接受治疗，并更有效率地利用资源。

是什么推动了血管闭合装置市场的成长？

血管闭合装置市场的成长受到多种因素的推动，例如全球心血管疾病盛行率的上升，这增加了对需要使用血管闭合装置 (VCD) 的介入手术的需求。技术进步提高了 VCD 的安全性和有效性，也促进了市场的扩张。此外，患者和医疗保健提供者对微创手术的日益偏好也推动了 VCD 的普及。此外，老年人口的成长也为市场提供了支撑，他们容易患血管疾病，使用 VCD 可显着加快康復速度。此外，医疗保健提供者专注于缩短手术时间和提高业务效率，这也推动了先进血管闭合技术的普及。

部分

类型（被动式介入器、主动式介入器、体外止血装置）；操作（介入性心臟病学、介入性放射学/血管外科）；入路（股动脉、桡动脉）

受访企业范例（共36家）

  • Cardinal Health, Inc.
  • Terumo Corporation
  • WL Gore & Associates, Inc.
  • Teleflex, Inc.
  • Cordis, a Cardinal Health company
  • Merit Medical Systems, Inc.
  • Elixir Medical Corporation
  • Tricol Biomedical, Inc.
  • Marine Polymer Technologies, Inc.
  • Axio Biosolutions Private Limited
  • Endocor GmbH

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP15452

Global Vascular Closure Devices Market to Reach US$1.4 Billion by 2030

The global market for Vascular Closure Devices estimated at US$938.2 Million in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Passive Approximators, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$996.3 Million by the end of the analysis period. Growth in the Active Approximators segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$387.1 Million While China is Forecast to Grow at 8.8% CAGR

The Vascular Closure Devices market in the U.S. is estimated at US$387.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$154.0 Million by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

Global Vascular Closure Devices Market - Key Trends & Drivers Summarized

What Are Vascular Closure Devices and How Do They Transform Patient Care?

Vascular closure devices (VCDs) are medical instruments used to seal puncture sites in arteries following cardiovascular procedures such as angiography or angioplasty. These devices offer a significant advancement over traditional manual compression methods, enhancing patient comfort and reducing the time required for hemostasis (the cessation of bleeding). VCDs fall into several categories, including collagen plugs, suture-based systems, and clip-based systems, each designed to provide rapid and reliable closure of arterial access sites. Their use minimizes the risk of complications such as bleeding and vascular injury, facilitating faster patient recovery and shorter hospital stays.

How Is Technological Innovation Impacting the VCD Market?

Technological advancements are at the forefront of driving innovations in the design and functionality of vascular closure devices. Recent developments include bioabsorbable materials that naturally dissolve in the body, reducing the risk of infection and other long-term complications associated with foreign objects left in the body. Additionally, advancements in device deployment mechanisms have led to more user-friendly designs that ensure more consistent and successful closures. Imaging technologies have also improved, aiding physicians in the accurate placement of VCDs, thereby increasing the efficacy and safety of procedures.

What Are the Clinical and Economic Benefits of Vascular Closure Devices?

From a clinical perspective, VCDs significantly enhance patient outcomes by reducing the incidence of complications associated with vascular access points. They enable immediate ambulation post-procedure, which is crucial for elderly patients or those with mobility issues. Economically, the use of VCDs can lead to cost savings for healthcare facilities by reducing the duration of post-procedure care and minimizing the need for additional staff during the recovery period. These devices also play a critical role in optimizing patient throughput in hospitals, allowing for the treatment of more patients and better utilization of resources.

What Drives the Growth in the Vascular Closure Devices Market?

The growth in the vascular closure devices market is driven by several factors, including the rising prevalence of cardiovascular diseases globally, which increases the demand for interventional procedures requiring VCDs. Technological advancements that enhance the safety and efficacy of these devices also contribute to market expansion. Additionally, the growing preference for minimally invasive surgeries among both patients and healthcare providers boosts the adoption of VCDs. The market is further supported by the increasing number of elderly populations, who are more prone to vascular diseases and benefit significantly from the quick recovery times associated with VCDs. Moreover, healthcare providers' emphasis on reducing procedure times and improving operational efficiencies continues to drive the adoption of advanced vascular closure technologies.

SCOPE OF STUDY:

The report analyzes the Vascular Closure Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Passive Approximators, Active Approximators, External Hemostatic Devices); Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery); Access (Femoral, Radial)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 36 Featured) -

  • Cardinal Health, Inc.
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
  • Teleflex, Inc.
  • Cordis, a Cardinal Health company
  • Merit Medical Systems, Inc.
  • Elixir Medical Corporation
  • Tricol Biomedical, Inc.
  • Marine Polymer Technologies, Inc.
  • Axio Biosolutions Private Limited
  • Endocor GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Vascular Closure Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Vascular Closure Devices - A Prelude
    • Benefits
    • Active Approximators
    • Passive Approximators
    • External Hemostatic Devices
    • Vascular Closure Devices to Witness Steady Growth Post COVID-19
    • Interventional Cardiology to Dominate the Market
    • Passive Approximators Lead the Market
    • Femoral Access Type Leads the Market
    • United States Holds a Dominant Share, Asia-Pacific to Witness Rapid Growth
    • Competition
    • Growth Restraints
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Medical Device Companies Focus on Developing Advanced Biomechanical VCDs
    • Increasing Demand for Large-bore Vascular Closure Devices
    • Select Large Bore Closure Devices
    • Cardiovascular Diseases: A Significant Contributor to Market Growth
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
    • Rising Preference for Minimally Invasive Procedures Boosts Market Prospects
    • Aging Population Drives Demand for Vascular Closure Devices
    • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
    • Increasing Healthcare Expenditure to Foster Growth
    • Recent Approvals and Launches
    • Essential Medical Inc Receives FDA Clearance for its Large-Bore Vascular Closure Device
    • Vascade MVP Vascular Closure System Obtains Approval from FDA
    • Large Bore PerQseal Closure Device Introduced in Europe
    • Cordis Introduces Mynx Control Vascular Closure Device
    • FDA Approves Teleflex's Vascular Closure Device
    • Vasorum Set to Commercialize a New Vascular Closure Device across the US
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Vascular Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Vascular Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 3: World 16-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Passive Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Passive Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 6: World 16-Year Perspective for Passive Approximators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Active Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Active Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 9: World 16-Year Perspective for Active Approximators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for External Hemostatic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for External Hemostatic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 12: World 16-Year Perspective for External Hemostatic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Interventional Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Interventional Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 15: World 16-Year Perspective for Interventional Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Interventional Radiology/Vascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Interventional Radiology/Vascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 18: World 16-Year Perspective for Interventional Radiology/Vascular Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Femoral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Femoral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 21: World 16-Year Perspective for Femoral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Radial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Radial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 24: World 16-Year Perspective for Radial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 25: World Vascular Closure Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • JAPAN
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • Graying Population Spurs Growth of Vascular Closure Devices
    • TABLE 24: Japanese Population by Age Group (2015 & 2040): Percentage Share Breakdown of Population for 0-14, 15-64 and 65 & Above Age Groups
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • CHINA
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • EUROPE
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • Ageing Demography - An Opportunity Indicator
    • European Population by Age Group (2016, 2030 & 2050): Percentage Share Breakdown by Age Group for 0-14, 15-64, and 65 & Above
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Vascular Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Vascular Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • FRANCE
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: France 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: France 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • GERMANY
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Spain 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Russia 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • Aging Populace - Potential Opportunities
    • Over 65 Years Individuals as % of the Total Population in Select Asian Countries
    • Healthcare Spending on the Rise
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Vascular Closure Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Australia 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • INDIA
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 158: India Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: India 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: India 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: India 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: South Korea 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Vascular Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Vascular Closure Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Latin America 16-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Argentina 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Brazil 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Mexico 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Rest of Latin America 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Vascular Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Vascular Closure Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Middle East 16-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: Iran 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Israel 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Saudi Arabia 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: UAE 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Rest of Middle East 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030
  • AFRICA
    • Vascular Closure Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: Africa 16-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2014, 2025 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2014, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2014, 2025 & 2030

IV. COMPETITION